The population had a wide range of age and obesity, markers of glucose metabolism (fasting glucose, 2-hour glucose and insulin sensitivity) as well as cardiovascular risk factors (Framingham risk score, total cholesterol and HDL cholesterol). The gene discussed is INS; the disease is obesity disorder.